Bedel Financial Consulting’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Hold |
10,000
| – | – | ﹤0.01% | 273 |
|
|
2025
Q1 | $3.57K | Hold |
10,000
| – | – | ﹤0.01% | 260 |
|
|
2024
Q4 | $3.8K | Hold |
10,000
| – | – | ﹤0.01% | 266 |
|
|
2024
Q3 | $32.4K | Hold |
10,000
| – | – | ﹤0.01% | 255 |
|
|
2024
Q2 | $30K | Hold |
10,000
| – | – | ﹤0.01% | 249 |
|
|
2024
Q1 | $46.5K | Hold |
10,000
| – | – | 0.01% | 251 |
|
|
2023
Q4 | $41.4K | Hold |
10,000
| – | – | 0.01% | 242 |
|
|
2023
Q3 | $30K | Hold |
10,000
| – | – | 0.01% | 234 |
|
|
2023
Q2 | $24.6K | Buy |
+10,000
| New | +$24.6K | 0.01% | 239 |
|